Stocks Health care CVM
NYSE · Health careCel Sci Corp (CVM)
It posted a net loss of $22.7M. In fiscal 2025 capital spending exceeded operating cash flow by $17.2M. At June 30, 2026 it held $6.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Cel Sci Corp does
Cel Sci Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NYSE under the ticker CVM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$25.4M | -$6.27 | -$17.2M |
| 2024 | n/a | -$26.9M | -$15.31 | -$18.9M |
| 2023 | n/a | -$32.4M | -$21.91 | -$23.2M |
| 2022 | n/a | -$36.7M | -$26.12 | -$18.9M |
| 2021 | n/a | -$36.4M | -$27.02 | -$27.8M |
| 2020 | n/a | -$30.3M | -$24.62 | -$17.9M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Cel Sci Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026
- August 17, 2026
- August 14, 2026
- July 2, 2026
- July 2, 2026Proxy statement DEF 14A
- June 16, 2026
- June 15, 2026
- May 27, 2026
- May 19, 2026
- May 15, 2026
Insider trades
What the people running Cel Sci Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $138K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 25, 2026 | Kersten Geert RChief Executive Officer, Director | Bought | 100,000 | $138K |
| June 30, 2026 | Kersten Geert RChief Executive Officer, Director | Received as pay | 5,192 | $5.4K |
| June 30, 2026 | Prichep Patricia BChief Financial Officer | Received as pay | 4,125 | $4.3K |
| June 30, 2026 | Talor EyalChief Scientific Officer | Received as pay | 2,307 | $2.4K |
Who owns CVM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lincoln Alternative Strategies LLC13G, passive | 6.94% | August 29, 2025 |
Largest institutional holders
Insiders
3 insiders reported holding 342,949 shares in total, about $572.7K at the last price.
| Holder | Shares |
|---|---|
| Kersten Geert RChief Executive Officer, Director | 316,142 |
| Prichep Patricia BChief Financial Officer | 17,489 |
| Talor EyalChief Scientific Officer | 9,318 |
Questions about CVM
What does Cel Sci Corp do?
Cel Sci Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NYSE under the ticker CVM.
Is Cel Sci Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $22.7M.
When did Cel Sci Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from September 3, 2026.
Similar companies
Compare CVM with
Follow CVM
Get an email when Cel Sci Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow CVM: get an email when it filesWhere the numbers come from
Financial figures are the values Cel Sci Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.